Michael Louis Shuler

Biochemical and Biomedical Engineering; Bioprocesses; "Body-on-a-chip" or Microphysiological Systems; Physiologically Based Pharmacokinetic (PBPK) Models; Drug Development Process.

 Currently I am in Emeritus status at Cornell University in Biomedical Engineering and in Chemical and Biomolecular Engineering and CEO and President of Hesperos, Inc .  I maintain an active lab at Cornell with two NIH funded grants.  Hesperos  ,Inc is a service company in providing human surrogates for testing potential drugs;  such technology is intended to develop useful drugs more cheaply than current technology based on animal testing.